- Feature Paper
- Article
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn’s Disease: A Prospective Cohort Study
- Luis G. Guijarro,
- Patricia de Castro-Martínez,
- María Chaparro,
- Julio Acero-Sanz,
- Diego de León,
- Iván Guerra,
- Marisa Iborra,
- José Luis Cabriada,
- Luis Bujanda and
- Cristina Alba
- + 13 authors
4 December 2025
Background and Objectives: Crohn’s Disease (CD) is a chronic inflammatory condition often treated with anti-TNF agents such as infliximab (IFX) and adalimumab (ADA). This study compares the efficacy, immunogenicity, and pharmacokinetics of IFX...